TTK Healthcare Q2 FY27 Revenue at ₹23,338 Lakhs; Net Profit ₹1,973 Lakhs
TTK Healthcare reported Q2 FY27 revenue of ₹23,338 lakhs and a net profit of ₹1,973 lakhs. A significant exceptional gain of ₹24,820 lakhs from the sale of 'EVA' and 'GoodHome' brands to Wipro Enterprises boosted Q2 net profit after tax to ₹22,297 lakhs. The company's half-year revenue was ₹52,648 lakhs.
The sale of major brands ('EVA' and 'GoodHome') and the resulting exceptional gain significantly impact the company's financial performance and strategic direction.
The company reported positive financial results, including a significant exceptional gain from the sale of brands, leading to a substantial increase in net profit.
TTK Healthcare Limited announced its unaudited financial results for the second quarter and half-year ended September 30, 2026. The Board of Directors approved these results in a meeting held on October 30, 2026, which commenced at 12 noon and concluded at 01:10 p.m. The company reported total income of ₹25,212.46 lakhs for the quarter, with a net profit before exceptional items and tax of ₹1,973.61 lakhs. For the half-year ended September 30, 2026, total income stood at ₹52,647.59 lakhs, and net profit before exceptional items and tax was ₹4,859.41 lakhs.
The company also reported a significant exceptional gain of ₹24,820.03 lakhs during the quarter related to the sale of its 'EVA' and 'GoodHome' brands and associated assets to Wipro Enterprises Private Limited, which was completed on September 04, 2026. This transaction resulted in a substantial net profit after tax of ₹22,297.26 lakhs for the quarter.
The financial results were reviewed by the Audit Committee and the statutory auditors. The company's website www.ttkhealthcare.com also hosts this information.
What to do with a filing like this
TTK Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by TTK Healthcare Limited. Read the original for the full detail.